Key Takeaways
- USAID funding cuts threatened healthcare for 400,000 people in Cameroon, impacting malnutrition treatment.
- GiveWell assessed humanitarian projects, including Cameroon's, to allocate $50 million after USAID reductions.
- GiveWell balanced rigorous data demands with urgent needs in unstable, dangerous operational zones.
- Despite data challenges, GiveWell approved a $1.9 million grant for ALIMA's Cameroon health project.
- International aid from major donors is declining, leading to global program shutdowns and data loss.
Deep Dive
- ALIMA, a group providing direct healthcare in Cameroon, annually treats nearly 400,000 people with services like vaccinations.
- ALIMA's Cameroon program was slated to receive $1.9 million from USAID before its funding was cut.
- The funding cut threatened treatment for malnourished children and projected 620,000 global deaths due to lack of care.
- GiveWell's rapid response team began assessing a project in Cameroon to meet its criteria for cost-effective life-saving.
- Operations were significantly reduced, with health facilities closing in Makari and Mokolo due to funding issues.
- Researchers sought demographic data for Mokolo Health District, approximately 350,000 people, including displaced individuals, to calculate lives saved.
- GiveWell required precise data, such as annual deaths of children under five per 10,000 people, which was difficult to obtain.
- On-the-ground research was not possible due to unstable and dangerous conditions in Cameroon, where researchers had been killed.
- The team weighed the risks of funding without comprehensive research against the urgency, noting that full research would take a year.
- Calculations indicated a syphilis testing program was significantly more cost-effective, saving vastly more lives per dollar than reducing maternal mortality.
- GiveWell questioned the Cameroon project's focus on conflict-affected areas versus areas with high mortality rates.
- The project explained its multifaceted health interventions, including nutritional paste and vaccines, were difficult to isolate for impact measurement.
- GiveWell's internal 'Botex' calculations suggested the Cameroon project was more effective than cash transfers, but required further analysis.
- The Cameroon team viewed GiveWell's extensive data inquiries as a sign of genuine interest despite the challenges.
- The Cameroon team reported scarce and informal recent mortality data, requesting GiveWell's deadlines for updated figures.
- GiveWell's Rosie estimated a 55-60% chance of the Cameroon project receiving funding.
- As of May 21st, the project faced staff cuts and reduced services, including suspended mental health and educational programs.
- This led to decreased access to care and mothers potentially delivering without medical assistance, exacerbated by the approaching rainy season.
- GiveWell researchers initially had concerns about the accuracy of data provided by ALIMA's Cameroon project due to lack of independent confirmation.
- A hospital director in Cameroon emphasized that ALIMA's project, including doctors, nurses, and nutrition services, was critical and its withdrawal would be a 'catastrophe.'
- Alice Redfern, initially skeptical, gained confidence, and Taryn noted a shift, realizing less certainty could yield greater future impact.
- On June 3rd, GiveWell approved a $1.9 million grant for ALIMA's work in Cameroon, enabling workers to restart paused projects.